Complete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025

Introduction

The 25th Annual San Diego Heart Failure Winter Symposium 2025 is a comprehensive cardiovascular education program focused on modern strategies for the detection, prevention, and treatment of heart failure across the full spectrum of disease severity. Organized by Complete Conference Management, the symposium delivers expert-led education integrating evidence-based heart failure management, guideline-directed therapies, cardiomyopathy evaluation, advanced cardiovascular interventions, and multidisciplinary patient care.

The curriculum combines:

• Heart failure prevention
• Guideline-directed medical therapy (GDMT)
• Cardiogenic shock management
• Cardiac amyloidosis
• Hypertrophic cardiomyopathy
• Inherited cardiomyopathies
• Sudden cardiac death prevention
• Structural and valvular heart disease
• Catheter-based cardiovascular interventions
• Percutaneous cardiac support devices

into a practical educational experience designed to improve cardiovascular outcomes and optimize heart failure management in both primary care and specialty practice.

Course Overview

📚 Program: Complete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025

🏛️ Organized by Complete Conference Management

🎥 Included Content

• 31 video lectures
• 26 PDF presentations

💾 Course Size: 9.51 GB

🎓 Educational Format

• Expert cardiovascular lectures
• Case-based discussions
• Interactive panel sessions
• Patient-centered perspectives
• Guideline-focused heart failure education

The symposium provides practical and evidence-based cardiovascular education applicable to both outpatient and advanced heart failure management.

Educational Focus

The program focuses on:

• Heart failure diagnosis and prevention
• Guideline-directed medical therapy
• Advanced heart failure management
• Cardiac amyloidosis
• Hypertrophic cardiomyopathy
• Genetic cardiomyopathies
• Cardiogenic shock
• Structural heart disease
• Atrial fibrillation interventions
• Percutaneous cardiovascular therapies

The curriculum emphasizes contemporary cardiovascular strategies designed to improve patient outcomes throughout all stages of heart failure.

Learning Objectives

After completing this activity, learners strengthen their ability to:

• Summarize current and emerging heart failure therapies
• Select evidence-based treatments for individual heart failure patients
• Implement guideline-directed medical and device therapies
• Improve outcomes using multidisciplinary cardiovascular management strategies
• Recognize special populations requiring individualized heart failure approaches
• Apply prevention and early detection strategies in high-risk cardiovascular patients
• Evaluate infiltrative and inherited cardiomyopathies
• Integrate advanced procedural and device-based therapies into clinical practice

The educational material emphasizes clinically practical and guideline-informed cardiovascular management.

Heart Failure Across the Disease Spectrum

A central focus of the symposium is comprehensive management across all stages of heart failure.

Covered Areas

• Stage A heart failure prevention
• Early asymptomatic cardiovascular disease
• Chronic symptomatic heart failure
• Advanced Stage D heart failure
• End-stage cardiovascular management
• Risk factor modification strategies

The curriculum reviews approaches ranging from prevention and early detection to advanced cardiovascular therapies.

Guideline-Directed Medical Therapy (GDMT)

Dedicated sessions focus on implementation of modern evidence-based pharmacologic strategies.

Topics Include

• Contemporary heart failure medications
• GDMT optimization strategies
• Emerging cardiovascular therapeutics
• Treatment personalization
• Long-term medication management
• Improving adherence and outcomes

Participants strengthen practical understanding of current heart failure guideline recommendations.

Cardiac Amyloidosis & Infiltrative Cardiomyopathies

Specialized educational sessions review infiltrative myocardial disease and advanced diagnostic approaches.

Educational Topics

• Cardiac amyloidosis recognition
• Infiltrative heart disease evaluation
• Advanced diagnostic strategies
• Disease-specific therapeutic approaches
• Imaging and clinical assessment

The sessions emphasize early identification and specialized management considerations.

Hypertrophic & Genetic Cardiomyopathies

The program includes comprehensive review of inherited and structural myocardial disorders.

Covered Areas

• Hypertrophic cardiomyopathy
• Genetic cardiomyopathies
• Risk stratification strategies
• Sudden cardiac death prevention
• Family screening considerations
• Longitudinal disease management

The curriculum highlights evolving approaches to inherited cardiovascular disease.

Cardiogenic Shock & Mechanical Support

Advanced cardiovascular care sessions focus on critically ill heart failure patients.

Topics Include

• Cardiogenic shock management
• Hemodynamic stabilization
• Percutaneous cardiac support devices
• Mechanical circulatory support concepts
• Acute heart failure interventions

Participants gain practical insight into advanced cardiovascular rescue therapies.

Electrophysiology & Sudden Cardiac Death Prevention

A major educational component involves rhythm management and prevention strategies.

Educational Areas

• Sudden cardiac death prevention
• Atrial fibrillation management
• Catheter-based rhythm interventions
• Electrophysiologic strategies in heart failure
• Device-based arrhythmia management

The sessions integrate arrhythmia care into comprehensive heart failure treatment.

Structural & Valvular Heart Disease

The symposium also reviews structural cardiovascular interventions relevant to heart failure populations.

Included Topics

• Valvular heart disease
• Catheter-based valve therapies
• Structural heart interventions
• Advanced cardiovascular imaging integration
• Procedural patient selection

The curriculum emphasizes practical integration of structural therapies into modern cardiovascular care.

Special Populations & Personalized Care

The educational content addresses diversity and individualized cardiovascular management strategies.

Covered Areas

• Women with heart failure
• Elderly cardiovascular patients
• Minority populations
• Personalized therapeutic approaches
• Population-specific treatment responses

The sessions highlight equitable and patient-centered cardiovascular care principles.

Educational Experience

The symposium combines:

• Expert-led cardiovascular education
• Interactive panel discussions
• Clinical case presentations
• Patient-centered perspectives
• Guideline-focused therapeutic review
• Advanced heart failure management strategies

The learning format emphasizes practical implementation of modern cardiovascular therapies into clinical practice.

Why This Symposium Stands Out

Comprehensive Heart Failure Coverage

Reviews prevention, diagnosis, treatment, and advanced cardiovascular management across all stages of disease.

Strong Guideline Integration

Emphasizes implementation of evidence-based heart failure therapies and GDMT optimization.

Advanced Cardiomyopathy Education

Includes specialized review of amyloidosis, infiltrative disorders, and inherited cardiomyopathies.

Multidisciplinary Cardiovascular Care

Highlights collaboration across primary care, internal medicine, and cardiology disciplines.

Practical Clinical Application

Focuses on strategies directly applicable to everyday cardiovascular practice.

Clinical Value

The Complete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025 delivers advanced cardiovascular education through integrated coverage of:

• Heart failure prevention and treatment
• Guideline-directed medical therapy
• Cardiac amyloidosis
• Hypertrophic cardiomyopathy
• Genetic cardiomyopathies
• Cardiogenic shock
• Mechanical circulatory support
• Sudden cardiac death prevention
• Atrial fibrillation management
• Structural and valvular heart disease
• Catheter-based cardiovascular interventions
• Multidisciplinary heart failure management

The combination of expert-led lectures, panel discussions, case-based learning, and guideline-focused cardiovascular education makes this symposium highly valuable for clinicians involved in the prevention and management of heart failure patients.

+ Topics:

• 01 Identifying Patients at Risk for Developing Heart Failure
• 02 Using SGLT inhibitors to Prevent CV Disease and Heart Failure
• 03 GLP-1 Agonists for Reducing Weight, Preventing CV Disease and Treating Heart Failure
• 04 Identifying and Treating Patients with Dyslipidemia
• 05 Use of Non-Steroidal MRAs To Prevent CV Disease, CKD and Heart Failure
• 06 Identifying Patients at Risk for Cardiac Toxicity from Chemotherapy – Update on How to Monitor and Preventive Strategies
• 07 Reducing Cardiovascular Risk in Our Patients- Case Presentation and Panel Discussion
• 08 Recognizing and Treating Patients with Amyloidosis
• 09 Cardiac Myosin Inhibitors and Other New Treatment Options for Patients with Hypertrophic Cardiomyopathy
• 10 Identifying and Treating Sarcoidosis and Other Infiltrative Diseases That Cause Heart Failure
• 11 Gene Therapy for Monogenic Causes of Heart Failure and Other Cardiovascular Disease
• 12 Pulmonary Arterial Hypertension (PAH)
• 13 Heart Failure Management in Adult Congenital Heart Disease
• 14 Peripartum Cardiomyopathy
• 15 Case Presentation and Panel Discussion
• 16 Coffee and Master Class on Physical Diagnosis
• 17 Monitoring Devices To Identify and Treat Congestion
• 18 Treating Patients with HFrEF-The Four Pillars of Therapy
• 19 Adjunctive Medical Therapy for Treating Patients with HFrEF
• 20 Treating Patients with HFpEF – How Do the Experts Do It
• 21 Using Biomarkers To Identify and Manage Heart Failure
• 22 Novel Approaches for Recognizing and Treating Congestion
• 23 How to Talk So Patients with Listen How to Listen So Patients Will Talk
• 24 Case Presentation
• 25 Identifying and Treating Cardiogenic Shock
• 26 Percutaneous Devices for Temporary Support of Cardiac Function
• 27 Catheter Based Treatments of Valvular Heart Disease
• 28 Left Atrial Occlusion Devices for Preventing Thromboemboli Complications of Atrial Fibrillation
• 29 Advances in Preventing Sudden Cardiac Death in Patients with Heart Failure
• 30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes
• 30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes
• 31 Palliative and Hospice Care for Patients with Advanced Heart Failure
• SDHF Winter Symposium 2025.pdf